These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 22642558)
1. Direct fluorescence monitoring of the delivery and cellular uptake of a cancer-targeted RGD peptide-appended naphthalimide theragnostic prodrug. Lee MH; Kim JY; Han JH; Bhuniya S; Sessler JL; Kang C; Kim JS J Am Chem Soc; 2012 Aug; 134(30):12668-74. PubMed ID: 22642558 [TBL] [Abstract][Full Text] [Related]
2. A theranostic prodrug based on FRET for real-time drug release monitoring in response to biothiols. Hu Y; Zeng F Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():77-85. PubMed ID: 28024642 [TBL] [Abstract][Full Text] [Related]
3. Gemcitabine-coumarin-biotin conjugates: a target specific theranostic anticancer prodrug. Maiti S; Park N; Han JH; Jeon HM; Lee JH; Bhuniya S; Kang C; Kim JS J Am Chem Soc; 2013 Mar; 135(11):4567-72. PubMed ID: 23461361 [TBL] [Abstract][Full Text] [Related]
4. Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects. Du Y; Zhang W; He R; Ismail M; Ling L; Yao C; Fu Z; Li X Bioorg Med Chem; 2017 Jun; 25(12):3247-3258. PubMed ID: 28465086 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and activity of a folate targeted monodisperse PEG camptothecin conjugate. Henne WA; Kularatne SA; Hakenjos J; Carron JD; Henne KL Bioorg Med Chem Lett; 2013 Nov; 23(21):5810-3. PubMed ID: 24064501 [TBL] [Abstract][Full Text] [Related]
6. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy. Wang Z; Wu H; Liu P; Zeng F; Wu S Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754 [TBL] [Abstract][Full Text] [Related]
7. An activatable theranostic for targeted cancer therapy and imaging. Bhuniya S; Maiti S; Kim EJ; Lee H; Sessler JL; Hong KS; Kim JS Angew Chem Int Ed Engl; 2014 Apr; 53(17):4469-74. PubMed ID: 24644015 [TBL] [Abstract][Full Text] [Related]
8. Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release. Xu Z; Hou M; Shi X; Gao YE; Xue P; Liu S; Kang Y Biomater Sci; 2017 Feb; 5(3):444-454. PubMed ID: 28058423 [TBL] [Abstract][Full Text] [Related]
9. Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy. Zhang F; Zhu G; Jacobson O; Liu Y; Chen K; Yu G; Ni Q; Fan J; Yang Z; Xu F; Fu X; Wang Z; Ma Y; Niu G; Zhao X; Chen X ACS Nano; 2017 Sep; 11(9):8838-8848. PubMed ID: 28858467 [TBL] [Abstract][Full Text] [Related]
10. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting. Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739 [TBL] [Abstract][Full Text] [Related]
11. CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells. Tian H; Huang Y; He J; Zhang M; Ni P ACS Appl Bio Mater; 2021 May; 4(5):4422-4431. PubMed ID: 35006854 [TBL] [Abstract][Full Text] [Related]
12. Disulfide-based multifunctional conjugates for targeted theranostic drug delivery. Lee MH; Sessler JL; Kim JS Acc Chem Res; 2015 Nov; 48(11):2935-46. PubMed ID: 26513450 [TBL] [Abstract][Full Text] [Related]
13. Integrating a novel SN38 prodrug into the PEGylated liposomal system as a robust platform for efficient cancer therapy in solid tumors. Fang T; Dong Y; Zhang X; Xie K; Lin L; Wang H Int J Pharm; 2016 Oct; 512(1):39-48. PubMed ID: 27544846 [TBL] [Abstract][Full Text] [Related]
14. Hepatocyte-targeting single galactose-appended naphthalimide: a tool for intracellular thiol imaging in vivo. Lee MH; Han JH; Kwon PS; Bhuniya S; Kim JY; Sessler JL; Kang C; Kim JS J Am Chem Soc; 2012 Jan; 134(2):1316-22. PubMed ID: 22171762 [TBL] [Abstract][Full Text] [Related]
15. The self-assembly of anticancer camptothecin-dipeptide nanotubes: a minimalistic and high drug loading approach to increased efficacy. Kim SH; Kaplan JA; Sun Y; Shieh A; Sun HL; Croce CM; Grinstaff MW; Parquette JR Chemistry; 2015 Jan; 21(1):101-5. PubMed ID: 25384556 [TBL] [Abstract][Full Text] [Related]
16. Reduction stimuli-responsive unimolecular polymeric prodrug based on amphiphilic dextran-framework for antitumor drug delivery. Bai S; Gao YE; Ma X; Shi X; Hou M; Xue P; Kang Y; Xu Z Carbohydr Polym; 2018 Feb; 182():235-244. PubMed ID: 29279120 [TBL] [Abstract][Full Text] [Related]
17. Novel tumor-targeted RGD peptide-camptothecin conjugates: synthesis and biological evaluation. Dal Pozzo A; Ni MH; Esposito E; Dallavalle S; Musso L; Bargiotti A; Pisano C; Vesci L; Bucci F; Castorina M; Foderà R; Giannini G; Aulicino C; Penco S Bioorg Med Chem; 2010 Jan; 18(1):64-72. PubMed ID: 19942441 [TBL] [Abstract][Full Text] [Related]
18. Acidity-responsive shell-sheddable camptothecin-based nanofibers for carrier-free cancer drug delivery. Zhou Z; Piao Y; Hao L; Wang G; Zhou Z; Shen Y Nanoscale; 2019 Aug; 11(34):15907-15916. PubMed ID: 31414111 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and optimization of a bifunctional hyaluronan-based camptothecin prodrug. Xu Z; Zheng W; Yin Z Arch Pharm (Weinheim); 2014 Apr; 347(4):240-6. PubMed ID: 24402828 [TBL] [Abstract][Full Text] [Related]
20. Development of albumin-binding camptothecin prodrugs using a Peptide positional scanning library. Schmid B; Warnecke A; Fichtner I; Jung M; Kratz F Bioconjug Chem; 2007; 18(6):1786-99. PubMed ID: 17915955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]